Treatment-Resistant Depression: A Critique of Current Approaches

References

• Elkin I., Shea T., Watkins J., Imber S., Sotsky S., Collins J., Glass D., Pilkonis P., Leber W., Docherty J., Fiester S., Parloff M. National Institute of Mental Health treatment of depression collaborative research program: General effectiveness of treatments. Archives of General Psychiatry 1989; 46: 971–982
   PubMed Web of Science ®Google Scholar
• Hardy P. Notion de depression resistante. L'Encephale 1986; 12: 191–196
   Google Scholar
• Nierenberg A., Amsterdam J. Treatment-resistant depression: Definition and treatment approaches. Journal of Clinical Psychiatry 1990; 51: 39–47
   PubMedGoogle Scholar
• Quitkin F. The importance of dosage in prescribing antidepressants. British Journal of Psychiatry 1985; 147: 593–597
   PubMed Web of Science ®Google Scholar
• Chalmers J., Cowen P. Drug treatment of tricyclic-resistant depression. International Review of Psychiatry 1990; 2: 239–248
   Google Scholar
• Poirier M., Benkelfat C. Bonnes et mauvaises associations therapeutiques dans le traitement des depressions resistantes. L'Encephale 1986; 12: 225–230
   Google Scholar
• White K., Simpson G. Treatment-resistant depression. Psychiatric Annals 1987; 17: 274–278
   Google Scholar
• Ban T. Prolegomenon to the clinical prerequisite: Psychopharmacology and the classification of mental disorders. Progress in Neuro-Psychopharmacology and Biological Psychiatry 1987; 11: 527–580
   Web of Science ®Google Scholar
• Shea M., Pilkonis P., Beckham E., Collins J., Elkin I., Sotsky S., Docherty J. Personality disorders and treatment outcome in the NIMH treatment of depression collaborative research program. American Journal of Psychiatry 1990; 147: 711–718
   PubMed Web of Science ®Google Scholar
• Kennedy S., Joffe R. Pharmacological management of refractory depression. Canadian Journal of Psychiatry 1989; 34: 451–456
   Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd ed. rev. American Psychiatric Association, Washington, DC 1987
   Google Scholar
• Langer G., Neumark J., Koinig G., Graf M., Schonbeck G. Rapid psychotherapeutic effects of anaesthesia with isoflurane (ES narcotherapy) in treatment-refractory depressed patients. Neuropsychobiology 1985; 14: 118–120
   Google Scholar
• Allen R. Treatment resistant depression and electroconvulsive treatment: One approach. American Journal of Social Psychiatry 1984; 4: 44–46
   Google Scholar
• Black D., Wilcox J., Stewart M. The use of ECT in children: Case report. Journal of Clinical Psychiatry 1985; 46: 98–99
   Google Scholar
• Dessauer M., Goetze U., Tolle R. Periodic sleep deprivation in drug-refractory depression. Ncuropsychobiology 1985; 13: 111–116
   PubMed Web of Science ®Google Scholar
• Ayd F. Psychostimulant therapy for depressed medically ill patients. Psychiatric Annals 1985; 15: 462–465
   Google Scholar
• Linet L. Treatment of a refractory depression with a combination of fluoxetine and d-amphetamine. American Journal of Psychiatry 1989; 146: 803–804
   PubMedGoogle Scholar
• Fennell M., Teasdale J. Cognitive therapy with chronic, drug-refractory depressed outpatients: A note of caution. Cognitive Therapy and Research 1982; 6: 455–459
   Google Scholar
• Johnson G. Lithium in depression: A review of the antidepressant and prophylactic effects of lithium. Australian and New Zealand Journal of Psychiatry 1987; 21: 356–365
   PubMed Web of Science ®Google Scholar
• Nelson J., Mazure C. Lithium augmentation in psychotic depression refractory to combined drug treatment. American Journal of Psychiatry 1986; 143: 363–366
   PubMed Web of Science ®Google Scholar
• Donaldson S. Tolerance to phenelzine in subsequent refractory depression: Three cases. Journal of Clinical Psychiatry 1989; 50: 33–35
   PubMedGoogle Scholar
• Price L., Charney D., Heninger G. Efficacy of lithium-tranylcypromine treatment in refractory depression. American Journal of Psychiatry 1985; 142: 619–623
   PubMed Web of Science ®Google Scholar
• Kramlinger K., Post R. The addition of lithium to carbamazepine. Archives of General Psychiatry 1989; 46: 794–800
   PubMedGoogle Scholar
• Delgado P., Price L., Charney D., Heninger G. Efficacy of fluvoxamine in treatment-refractory depression. Journal of Affective Disorders 1988; 15: 55–60
   PubMed Web of Science ®Google Scholar
• Feigner J., Boyer W., Tyler D., Neborsky R. Adverse consequences of fluoxetine-MAOI combination therapy. Journal of Clinical Psychiatry 1990; 51: 222–225
   Google Scholar
• Gelzer G. Limits to chemotherapy of depression. Psychopathology 1986; 19: 108–117
   Google Scholar
• Price L., Charney D., Heninger G. Variability of response to lithium augmentation in refractory depression. American Journal of Psychiatry 1986; 143: 1387–1392
   PubMed Web of Science ®Google Scholar
• Price L., Charney D., Heninger G. Reserpine augmentation of desipramine in refractory depression: Clinical and neurobiological effects. Psychopharmacology 1987; 92: 431–437
   Google Scholar
• Lafferman J., Solomon K., Ruskin P. Lithium augmentation for treatment-resistant depression in the elderly. Journal of Geriatric Psychiatry and Neurology 1988; 1: 49–52
   PubMedGoogle Scholar
• Nierenberg A., Price L., Charney D., Heninger G. After lithium augmentation: A retrospective follow-up of patients with antidepressant-refractory depression. Journal of Affective Disorders 1990; 18: 167–175
   PubMedGoogle Scholar
• Charney D., Price L., Heninger G. Desipramine-yohimbine combination treatment of refractory depression. Archives of General Psychiatry 1986; 43: 1155–1161
   PubMedGoogle Scholar
• Targum S., Greenberg R., Harmon R., Kessler K., Salerian A., Fram D. Thyroid hormone and the TRH stimulation test in refractory depression. Journal of Clinical Psychiatry 1984; 45: 345–346
   PubMed Web of Science ®Google Scholar
• Pope H., McElroy S., Nixon R. Possible synergism between fluoxetine and lithium in refractory depression. American Journal of Psychiatry 1988; 145: 1292–1294
   PubMed Web of Science ®Google Scholar
• Hullett F., Bidder T. Phenelzine plus triiodothyronine combination in a case of refractory depression. Journal of Nervous and Mental Disease 1983; 171: 318–320
   PubMedGoogle Scholar
• Deicken R. Combined alprazolam and phenelzine treatment of refractory depression with panic attacks. Biological Psychiatry 1987; 22: 762–766
   PubMedGoogle Scholar
• Lieff S., Herrmann N. Combined drug therapy for an elderly depressed patient. American Journal of Psychiatry 1988; 145: 1034–1035
   Google Scholar
• Kantor D., McNevin S., Leichner P., Harper D., Krenn M. The benefit of lithium carbonate adjunct in refractory depression: Fact or fiction?. Canadian Journal of Psychiatry 1986; 31: 416–418
   PubMedGoogle Scholar
• Antonuccio D., Akins W., Chatham P., Monagin J., Teaman B., Ziegler B. An exploratory study: The psychoeducational group treatment of drug-refractory unipolar depression. Journal of Behavior Therapy and Experimental Psychiatry 1984; 15: 309–313
   PubMed Web of Science ®Google Scholar
• Miller I., Bishop S., Norman W., Keitner G. Cognitive-behavioural therapy and pharmacotherapy with chronic, drug-refractory depressed inpatients: A note of optimism. Behavioural Psychotherapy 1985; 13: 320–327
   Google Scholar
• Arana G., Santos A., Knox E., Ballenger J. Refractory rapid cycling unipolar depression responds to lithium and carbamazepine treatment. Journal of Clinical Psychiatry 1989; 50: 356–357
   Google Scholar
• Cooke R. T3 augmentation of a tricylic antidepressant in a patient receiving T4 maintenance therapy. American Journal of Psychiatry 1990; 147: 255
   Google Scholar
• Fein S., Paz V., Rao N., LaGrassa J. The combination of lithium carbonate and an MAOI in refractory depressions. American Journal of Psychiatry 1988; 145: 249–250
   PubMedGoogle Scholar
• Guze B., Baxter L., Rego J. Refractory depression treated with high doses of a monoamine oxidase inhibitor. Journal of Clinical Psychiatry 1987; 48: 31–32
   Google Scholar
• Joffe R. Triiodothyronine potentiation of the antidepressant effect of phenelzine. Journal of Clinical Psychiatry 1988; 49: 409–410
   Google Scholar
• Katz S. Tardive dyskinesia associated with molindone treatment. American Journal of Psychiatry 1990; 147: 124–125
   Google Scholar
• Madakasira S. Low dose potency of lithium in antidepressant augmentation. Psychiatric Journal of the University of Ottawa 1986; 11: 107–109
   Google Scholar
• Ontiveros A., Fontaine R., Elie R. Refractory depression: The addition of lithium to fluoxetine or desipramine. Acta Psychiatrica Scandinavica 1991; 83: 188–192
   PubMed Web of Science ®Google Scholar
• Pearlman C. High-dosage tranylcypromine in refractory depression. Journal of Clinical Psychiatry 1987; 48: 424–425
   Google Scholar
• Ryan N., Meyer V., Dachille S., Mazzie D., Puig-Antich J. Lithium antidepressant augmentation in TCA-refractory depression in adolescents. Journal of the American Academy of Child and Adolescent Psychiatry 1988; 27: 371–376
   PubMed Web of Science ®Google Scholar
• Solyom L., Gibson R. Fluoxetine in refractory depression. Biological Psychiatry 1990; 27: 461–463
   Google Scholar